New Journal Website is available at:

Published by: Neoscriber Demo Publisher

Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention

Mohsen Maadani 1 , Seifollah Abdi 1 , Sepideh Parchami-Ghazaee 1 , Keivan Alizadeh 1 , Hosein Fathi 1 and Reza Musavi 1 , *
Authors Information
1 Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: November 28, 2013, 2 (4); 169-73
  • Published Online: October 28, 2013
  • Article Type: Research Article
  • Received: April 15, 2013
  • Revised: August 15, 2013
  • Accepted: August 16, 2013
  • DOI: 10.5812/cardiovascmed.11542

To Cite: Maadani M, Abdi S, Parchami-Ghazaee S, Alizadeh K, Fathi H, et al. Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention, Res Cardiovasc Med. 2013 ;2(4):169-73. doi: 10.5812/cardiovascmed.11542.

Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
1. Backgrounds
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Yong ZY, Wiegerinck EM, Boerlage-van Dijk K, Koch KT, Vis MM, Bouma BJ, et al. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2012; 5(3): 415-23[DOI][PubMed]
  • 2. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv. 2010; 3(6): 602-10[DOI][PubMed]
  • 3. Cutlip DE, Kuntz RE. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation. 2005; 112(6): 916-22[PubMed]
  • 4. Kashyap ML. Cholesterol and atherosclerosis: a contemporary perspective. Ann Acad Med Singapore. 1997; 26(4): 517-23[PubMed]
  • 5. Reddy RK, Reddy S, Kumar AN. Lipid profile levels on the second day of acute myocardial infarction; is it the right time for estimation. Internet J Med. 2012; 7(1): 52-5
  • 6. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58(24)-122[DOI][PubMed]
  • 7. Young DS. Effects of disease on Clinical Lab.Tests. Young DS Effects of disease on Clinical Lab.Tests. 2001;
  • 8. Aldous SJ. Cardiac biomarkers in acute myocardial infarction. Int J Cardiol. 2013; 164(3): 282-94[DOI][PubMed]
  • 9. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007; 28(20): 2525-38[DOI][PubMed]
  • 10. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, et al. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med. 2001; 2(4): 187-194[DOI][PubMed]
  • 11. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 1996; 94(7): 1528-36[PubMed]
  • 12. Patil N, Chavan V, Karnik ND. Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem. 2007; 22(1): 45-51[DOI][PubMed]
  • 13. Kumar A, Sivakanesan R. Serum lipid profile abnormality in predicting the risk of myocardial infarction in elderly normolipidaemic patients in South Asia: A case-controlled study. Internet J Altern Med. 2009; 6(2): 6
  • 14. Hodis HN. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 1999; 99(22): 2852-4[PubMed]
  • 15. Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation. 2000; 102(16): 1886-92[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader